ATE318324T1 - Verfahren zur herstellung von oligosaccharide - Google Patents

Verfahren zur herstellung von oligosaccharide

Info

Publication number
ATE318324T1
ATE318324T1 AT00949678T AT00949678T ATE318324T1 AT E318324 T1 ATE318324 T1 AT E318324T1 AT 00949678 T AT00949678 T AT 00949678T AT 00949678 T AT00949678 T AT 00949678T AT E318324 T1 ATE318324 T1 AT E318324T1
Authority
AT
Austria
Prior art keywords
cell
intermediates
degrading
culturing
modification
Prior art date
Application number
AT00949678T
Other languages
English (en)
Inventor
Eric Samain
Bernard Priem
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547804&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE318324(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE318324T1 publication Critical patent/ATE318324T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
AT00949678T 1999-07-07 2000-07-07 Verfahren zur herstellung von oligosaccharide ATE318324T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908772A FR2796082B1 (fr) 1999-07-07 1999-07-07 Procede de production d'oligosaccharides

Publications (1)

Publication Number Publication Date
ATE318324T1 true ATE318324T1 (de) 2006-03-15

Family

ID=9547804

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00949678T ATE318324T1 (de) 1999-07-07 2000-07-07 Verfahren zur herstellung von oligosaccharide
AT05111263T ATE466094T1 (de) 1999-07-07 2000-07-07 Verfahren zur herstellung von oligosacchariden

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05111263T ATE466094T1 (de) 1999-07-07 2000-07-07 Verfahren zur herstellung von oligosacchariden

Country Status (11)

Country Link
US (2) US7521212B1 (de)
EP (2) EP1194584B1 (de)
JP (1) JP5058420B2 (de)
AT (2) ATE318324T1 (de)
AU (1) AU780290B2 (de)
CA (1) CA2378562C (de)
DE (2) DE60026142T2 (de)
FR (1) FR2796082B1 (de)
MX (1) MXPA02000240A (de)
NZ (1) NZ516808A (de)
WO (1) WO2001004341A1 (de)

Families Citing this family (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4259876B2 (ja) * 2001-04-02 2009-04-30 株式会社グライコメディクス オリゴ糖鎖の生産方法
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
US7820422B2 (en) 2005-06-16 2010-10-26 Centre National De La Recherche Scientifique (Cnrs) Efficient production of oligosaccharides using metabolically engineered microorganisms
WO2008002230A1 (en) * 2006-03-04 2008-01-03 Nilsson Kurt G I Production of glycoside oligosaccharides
PT1991690E (pt) 2006-03-09 2014-04-22 Centre Nat Rech Scient Método para a produção de oligossacáridos sialilados
EP1911850A1 (de) * 2006-10-09 2008-04-16 Centre National De La Recherche Scientifique (Cnrs) Verfahren zur Herstellung von 6-thio-sialierten Glykoproteinen und Glycokonjugaten
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
US9237764B2 (en) 2010-02-19 2016-01-19 Glycom A/S Production of 6′-O-sialyllactose and intermediates
PH12013500068A1 (en) 2010-07-12 2016-11-16 Inbiose Nv Metabolically engineered organisms for the production of added value bio-products
RU2460800C2 (ru) * 2010-08-04 2012-09-10 Государственное научное учреждение Всероссийский научно-исследовательский институт сельскохозяйственной микробиологии Российской академии сельскохозяйственных наук (ГНУ ВНИИСХМ Россельхозакадемии) Способ ферментативного получения пента-n-ацетилхитопентаозы
CA3098403C (en) 2011-02-16 2022-05-10 Glycosyn LLC Biosynthesis of human milk oligosaccharides in engineered bacteria
EP2707379A4 (de) 2011-05-13 2014-10-08 Glycosyn LLC Verwendung gereinigter 2'-fucosyllactose, 3-fucosyllactose und lactodifucotetraose als präbiotika
CN103764835B (zh) 2011-06-07 2016-08-17 海罗公司 通过生物技术方法获取低聚糖
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
IN2014CN02468A (de) 2011-09-08 2015-06-19 Novozymes Bioag As
CA2848856C (en) 2011-09-14 2020-04-28 Novozymes Bioag A/S Use of lipochito-oligosaccharides and/or chito-oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth
AU2012312009B2 (en) 2011-09-23 2015-11-26 Novozymes Bioag A/S Combinations of lipo-chitooligosaccharides and methods for use in enhancing plant growth
MX2014003411A (es) 2011-09-23 2015-03-19 Novozymes Bioag As Quitooligosacaridos y metodos para el uso en el mejoramiento del crecimiento del maiz.
ES2613396T3 (es) 2011-09-23 2017-05-24 Novozymes Bioag A/S Quitooligosacáridos y métodos para uso en el aumento del crecimiento de soja
MX351416B (es) 2011-09-23 2017-10-13 Novozymes Bioag As Quitooligosacaridos y metodos para el uso en el mejoramiento de crecimiento de plantas.
US20150225758A1 (en) * 2011-11-08 2015-08-13 University Of Georgia Research Foundation, Inc. Genetically modified cells and methods for making activated sugar-nucleotides
CN103155816A (zh) * 2011-12-09 2013-06-19 青岛天力建筑加固工程有限公司 一种使单体树木便于靠接成整棵大树的模具
RU2517620C2 (ru) * 2012-02-17 2014-05-27 Государственное научное учреждение Всероссийский научно-исследовательский институт сельскохозяйственной микробиологии Российской академии сельскохозяйственных наук (ГНУ ВНИИСХМ Россельхозакадемии) Способ ферментативного получения пента-n-ацетилхитопентаозы и гекса-n-ацетилхитогексаозы
EP2859112A4 (de) 2012-06-08 2015-10-28 Glycom As Verfahren zur herstellung von oligosacchariden und oligosaccharidglykosiden durch fermentation
WO2014048439A1 (en) * 2012-09-25 2014-04-03 Glycom A/S Glycoconjugate synthesis
ES2640978T3 (es) 2012-10-31 2017-11-07 Jennewein Biotechnologie Gmbh Proceso de producción de monosacáridos
WO2014086373A1 (en) 2012-12-07 2014-06-12 Glycom A/S Crystallisation of human milk oligosaccharides (hmo)
EP2970872B1 (de) * 2013-03-14 2018-09-05 Glycosyn LLC Mikroorganismen und verfahren zur herstellung sialylierter und n-acetylglucosamin-haltiger oligosaccharide
ES2891731T3 (es) 2013-05-22 2022-01-31 Glycom As Mezcla sintética de oligosacáridos para el tratamiento de la microbiota de un mamífero
EP3041947A4 (de) 2013-09-06 2017-07-26 Glycom A/S Fermentative herstellung von oligosacchariden
WO2015032412A1 (en) 2013-09-06 2015-03-12 Glycom A/S Fermentative production of oligosaccharides
ES2701163T3 (es) 2014-01-20 2019-02-21 Jennewein Biotechnologie Gmbh Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana
PL2927316T3 (pl) 2014-03-31 2019-05-31 Jennewein Biotechnologie Gmbh Całkowita fermentacja oligosacharydów
KR20230113650A (ko) * 2014-05-15 2023-07-31 글리코신 엘엘씨 푸코실레이티드 올리고당의 제조에 사용되는 알파(1,2)푸코실트랜스퍼라아제 동질 유전자형
ES2968677T3 (es) 2014-06-11 2024-05-13 Glycom As Separación de 2’-O-fucosil-lactosa de caldo de fermentación
US11926858B2 (en) 2014-06-27 2024-03-12 Glycom A/S Oligosaccharide production
EP4477741A3 (de) 2014-06-27 2025-03-05 Glycom A/S Herstellung von oligosacchariden
CN106536726A (zh) * 2014-07-14 2017-03-22 巴斯夫欧洲公司 LNT、LNnT和其岩藻糖基化衍生物的生物技术生产
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
PL3209673T5 (pl) 2014-10-24 2023-10-23 Glycom A/S Mieszaniny hmo
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20160346303A1 (en) 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
WO2016066174A1 (en) 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for promoting mucosal healing
WO2016086947A1 (en) 2014-12-05 2016-06-09 Glycom A/S Crystalline difucosyllactose
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10828313B2 (en) 2014-12-08 2020-11-10 Glycom A/S Synthetic composition for treating metabolic disorders
ES2933616T3 (es) 2014-12-16 2023-02-10 Glycom As Separación de 2'-FL de un caldo de fermentación
ES2971093T3 (es) 2015-03-31 2024-06-03 Glycom As Mezclas de oligosacáridos de la leche humana que comprenden 3'-O-sialilactosa
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10695359B2 (en) 2015-06-09 2020-06-30 Glycom A/S Ternary mixtures of 6′-SL, LNnT and LST c
EP3141610A1 (de) 2015-09-12 2017-03-15 Jennewein Biotechnologie GmbH Herstellung von menschlichen milch-oligosacchariden in mikrobiellen wirten mit gentechnisch verändertem import/export-system
WO2017046711A1 (en) 2015-09-14 2017-03-23 Glycom A/S Synthetic composition for microbiota modulation
PL3368046T3 (pl) 2015-10-28 2022-11-28 Glycom A/S Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
WO2017071716A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
WO2017084673A1 (en) 2015-11-17 2017-05-26 Glycom A/S Synthetic Composition for Treating Antibiotic Associated Complications
MY186217A (en) 2015-12-15 2021-06-30 Nestle Sa Mixture of hmos
WO2017101958A1 (en) 2015-12-18 2017-06-22 Glycom A/S Fermentative production of oligosaccharides
EP3419630A4 (de) 2016-02-24 2019-11-06 Glycom A/S Synthetische zusammensetzung zur mikrobiota-modulation
EP3426670B1 (de) 2016-03-07 2024-08-07 Glycom A/S Abtrennung von oligosacchariden aus einer fermentationsbrühe
EP4674526A2 (de) 2016-04-19 2026-01-07 Glycom A/S Trennung von oligosacchariden aus fermentationsbrühe
PL3452051T3 (pl) 2016-05-05 2022-11-14 Glycom A/S Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi
ES2938355T3 (es) 2016-05-05 2023-04-10 Glycom As Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa
WO2017198276A1 (en) 2016-05-19 2017-11-23 Glycom A/S Synthetic composition
EP3474861A4 (de) 2016-06-24 2020-04-15 Glycom A/S Zusammensetzungen mit hmos, deren herstellung und verwendung zur prävention und/oder behandlung von viralen und/oder bakteriellen infektionen
DK3315610T3 (da) * 2016-10-29 2021-03-08 Jennewein Biotechnologie Gmbh Fremgangsmåde til fremstilling af fucosylerede oligosaccharider
US10407516B2 (en) 2016-10-31 2019-09-10 Glycom A/S Crystalline HMO
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
WO2018157900A1 (en) 2017-03-01 2018-09-07 Glycom A/S Synthetic composition for microbiota modulation
US11291677B2 (en) 2017-05-09 2022-04-05 Glycom A/S Synthetic composition for microbiota modulation
EP3630123A4 (de) 2017-05-24 2020-10-28 Glycom A/S Synthetische zusammensetzung mit einem oder mehreren menschlichen milcholigosacchariden (hmos)
EP3630124A4 (de) 2017-05-24 2021-02-24 Glycom A/S Synthetische zusammensetzung mit oligosacchariden und ihre verwendung bei medizinischen behandlungen
US12065462B2 (en) 2017-06-30 2024-08-20 Glycom A/S Purification of oligosaccharides
WO2019012461A1 (en) 2017-07-12 2019-01-17 Glycom A/S AMORPHOUS MIXTURE COMPRISING A NEUTRAL MONO- OR OLIGOSACCHARIDE AND A NON-GLUCIDIC ACID COMPONENT
EP3438122A1 (de) 2017-08-01 2019-02-06 OligoScience Biotechnology GmbH Mikroorganismus zur herstellung menschlicher milcholigosaccharide
EP3672600A4 (de) 2017-08-21 2021-05-19 Glycom A/S Synthetische zusammensetzung zur verminderung von allergiesymptomen
EP3450443A1 (de) 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Verfahren zur reinigung sialylierter oligosaccharide
EP3456836A1 (de) 2017-09-13 2019-03-20 Glycom A/S Abtrennung von sialylierten oligosacchariden aus der fermentationsbrühe
MX2020004133A (es) 2017-10-04 2020-08-13 Univ California Oligosacaridos inmunomoduladores.
GB201717555D0 (en) 2017-10-25 2017-12-06 Nonwovens Innovation & Res Institute Ltd Blood filter
CN111526879A (zh) 2017-11-02 2020-08-11 格礼卡姆股份公司 用于减少或预防疲劳和/或改善注意力或专注力的一种或多种hmo
KR20200096263A (ko) 2017-11-30 2020-08-11 글리콤 에이/에스 밀 민감증을 치료하기 위한 hmo 혼합물
WO2019111115A2 (en) 2017-12-05 2019-06-13 Glycom A/S Human milk oligosaccharides for treating migraine
US11304966B2 (en) 2017-12-22 2022-04-19 Glycom A/S Composition comprising HMOs for preventing or reducing nociception
CN108504678A (zh) * 2018-04-12 2018-09-07 江南大学 一种提高重组枯草芽孢杆菌几丁寡糖产量的方法
EP3790413A1 (de) 2018-05-07 2021-03-17 Jennewein Biotechnologie GmbH Einfaches verfahren zur reinigung von lacto-n-neotetraose (lnnt) aus durch mikrobielle fermentation erhaltenen kohlenhydraten
BR112020022892A2 (pt) 2018-05-31 2021-02-23 Glycom A/S mistura de hmos para tratamento de doenças autoi-munes
EP3620510B1 (de) 2018-09-06 2023-11-01 Chr. Hansen HMO GmbH Fermentative herstellung von oligosacchariden durch gesamtfermentation mit einem gemischten futtermittel
CN113166789B (zh) * 2018-12-04 2025-03-28 格礼卡姆股份公司 岩藻糖基化寡糖lnfp-v的合成
BR112021011071A2 (pt) 2018-12-19 2021-08-31 Glycom A/S Composição e método para o tratamento de seres humanos utilizando dietas com baixo teor de fodmap
EP3702468A1 (de) 2019-03-01 2020-09-02 Jennewein Biotechnologie GmbH Fermentative produktion von kohlenhydraten durch mikrobielle zellen, die ein gemischtes ausgangsmaterial verwenden
EP3741770A1 (de) 2019-05-21 2020-11-25 Jennewein Biotechnologie GmbH Reinigung von oligosacchariden aus einem fermentationsmedium mittels filtration
WO2021094133A2 (en) 2019-11-13 2021-05-20 Basf Se Enzymatic hydrolysis of 2',3-difucosyllactose
EP4065128A4 (de) 2019-11-29 2023-12-20 Glycom A/S Mischung von hmos zur verbesserung der mikrobiota von schwangeren frauen
US20230212628A1 (en) 2019-12-18 2023-07-06 Inbiose N.V. Production of Sialylated Oligosaccharide in Host Cells
CN114829619A (zh) * 2019-12-19 2022-07-29 格礼卡姆股份公司 从发酵液中分离唾液酸化寡糖
CA3161898A1 (en) 2019-12-19 2021-06-24 Basf Se Increasing space-time-yield, carbon-conversion-efficiency and carbon substrate flexibility in the production of fine chemicals
EP4121436A1 (de) * 2020-02-24 2023-01-25 Carbocode S.A. Herstellung von glycosylfluoriden
WO2021181349A1 (en) 2020-03-12 2021-09-16 Glycom A/S Crystallization of 2'-fl
FR3110176B1 (fr) 2020-05-12 2022-05-13 Institut Nat Des Sciences Appliquees De Toulouse Souche et procédé de production d’oligosaccharides
CN115803443A (zh) 2020-07-13 2023-03-14 格礼卡姆股份公司 寡糖的制造
EP4192944A1 (de) * 2020-08-10 2023-06-14 Inbiose N.V. Herstellung von oligosaccharidgemischen durch eine zelle
ES2966260T3 (es) 2020-08-10 2024-04-19 Inbiose Nv Producción de una mezcla de oligosacáridos neutros no fucosilados por una célula
WO2022034078A1 (en) * 2020-08-10 2022-02-17 Inbiose N.V. Method to produce a purified mixture of different oligosaccharides produced by cell cultivation or microbial fermentation
EP4255444A4 (de) 2020-12-04 2024-10-16 Glycom A/S Muttermilcholigosaccharide zur verwendung bei der unterstützung der reifung oder verbesserung von schlafmustern
US20240050582A1 (en) 2021-03-08 2024-02-15 Universiteit Gent Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed
DK181061B1 (en) 2021-03-12 2022-10-31 Glycom As Purification of sialooligosaccharides
WO2022223430A1 (en) 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
WO2022243311A1 (en) 2021-05-17 2022-11-24 Dsm Ip Assets B.V. Microbial strain expressing an invertase/sucrose hydrolase
BE1029436B1 (nl) 2021-06-15 2023-07-31 Dsm Ip Assets Bv Scheiding van moedermelkoligosachariden uit een fermentatiebouillon
EP4355463A1 (de) 2021-06-15 2024-04-24 DSM IP Assets B.V. Trennung von menschlichen milcholigosacchariden aus einer fermentationsbrühe
US20250128210A1 (en) 2021-06-15 2025-04-24 Dsm Ip Assets B.V. Separation of human milk oligosaccharides from a fermentation broth
BE1029437B1 (nl) 2021-06-15 2023-07-31 Dsm Ip Assets Bv Scheiding van moedermelkoligosachariden uit een fermentatiebouillon
CN115873051B (zh) * 2022-05-17 2024-06-25 山东恒鲁生物科技有限公司 三糖的新晶型
US20250376707A1 (en) 2022-06-14 2025-12-11 Dsm Ip Assets B.V. Separation of human milk oligosaccharides from a fermentation broth
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs
WO2025045721A1 (en) 2023-08-25 2025-03-06 Chr. Hansen A/S N-acetylglucosaminyltransferase enzymes with altered substrate specificity and their use in fermentative oligosaccharide production

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI883076L (fi) * 1987-10-29 1989-04-30 Sgn Soc Gen Tech Nouvelle Framstaellningsfoerfarande foer kombinering av mycket fruktoshaltiga oligosider och glukonsyra med hjaelp av jaesning.
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
JPH02273192A (ja) * 1989-04-13 1990-11-07 Meito Sangyo Kk イソマルチユロースの製造方法
JPH09503905A (ja) * 1993-07-15 1997-04-22 ネオゼ ファーマシューティカルス 糖組成物の合成方法
EP0723010A4 (de) 1994-05-19 2000-09-27 Bio Polymer Res Co Ltd Mit einem auf den zuckermetabolismus bezogenem gen transformiertes cellulose produzierendes bakterium
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
JP3403205B2 (ja) 1996-09-17 2003-05-06 協和醗酵工業株式会社 糖ヌクレオチド類および複合糖質の製造法
US5945314A (en) * 1997-03-31 1999-08-31 Abbott Laboratories Process for synthesizing oligosaccharides
DE19735994A1 (de) * 1997-08-19 1999-02-25 Piepersberg Wolfgang Prof Dr Verfahren zur enzymatischen Synthese von Guanosindiphosphat-6-desoxyhexosen und deren Verwendung zur Herstellung von Oligosacchariden
MXPA01004982A (es) * 1998-11-18 2004-09-27 Neose Technologies Inc Manufactura de bajo costo de oligosacaridos.
WO2000070060A1 (en) * 1999-05-18 2000-11-23 University Of Iowa Research Foundation Production of complex carbohydrates
JP2001546898A (en) 1999-12-21 2003-06-10 Kyowa Hakko Kogyo Kk MODIFIED alpha -1,2-FUCOSYLTRANSFERASE GENE AND PROCESS FOR PRODUCING alpha -1,2-FUCOSYLTRANSFERASE AND FUCOSE-CONTAINING SUGAR CHAIN
US20040058418A1 (en) 2000-04-11 2004-03-25 Tetsuo Endo Alpha 1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate

Also Published As

Publication number Publication date
DE60026142D1 (de) 2006-04-27
US20090082307A1 (en) 2009-03-26
JP2003504072A (ja) 2003-02-04
FR2796082A1 (fr) 2001-01-12
FR2796082B1 (fr) 2003-06-27
EP1194584A1 (de) 2002-04-10
AU6296100A (en) 2001-01-30
CA2378562A1 (fr) 2001-01-18
US8586332B2 (en) 2013-11-19
AU780290B2 (en) 2005-03-17
EP1194584B1 (de) 2006-02-22
ATE466094T1 (de) 2010-05-15
CA2378562C (fr) 2013-11-26
NZ516808A (en) 2004-07-30
US7521212B1 (en) 2009-04-21
DE60044310D1 (de) 2010-06-10
EP1637611B1 (de) 2010-04-28
MXPA02000240A (es) 2002-06-21
JP5058420B2 (ja) 2012-10-24
EP1637611A1 (de) 2006-03-22
WO2001004341A1 (fr) 2001-01-18
DE60026142T2 (de) 2006-11-23

Similar Documents

Publication Publication Date Title
ATE466094T1 (de) Verfahren zur herstellung von oligosacchariden
ATE527367T1 (de) Herstellung von oligosacchariden in transgenen pflanzen
Mayer et al. Enzyme-initiated domino (cascade) reactions
WO2002101019A3 (en) Methods of culturing animal cells and polypeptide production in animal cells
BR0012712B1 (pt) métodos de produção de l-aminoácidos aumentando-se o nadph celular.
CA2065839A1 (en) Method for Producing Secretable Glycosyltransferases and Other Golgi Processing Enzymes
ZA200605440B (en) Advanced microorganism for producing 1,2-propanediol
YU83101A (sh) Postupci i materijali za sinteze organskih proizvoda
WO1998014602A3 (en) Preparation of d-amino acids by direct fermentative means
DE69428889D1 (de) Verfahren zur herstellung von zucker durch starke, saure hydrolyse von zellulose-und hemizellulose enthaltende materialien
ATE452201T1 (de) Produktion modifizierter glykoproteine mit mehrfach verzweigten strukturen
AR076925A1 (es) Metodo para la produccion de azucares fermentables a partir de biomasa
MXPA04006357A (es) Metodos para disenar estructuras de carbohidrato del tipo de mamifero.
DE502004000547D1 (de) Verfahren zur fermentativen Herstellung von L-Methionin
MY162745A (en) Process for the direct production of fermentation products from biomasses in a biofilm reactor
PH12022550956A1 (en) Method for enzymatically producing high-activity biological organic fertilizer
ATE423199T1 (de) Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik
BRPI0606117A2 (pt) método de geração de ácido l-ascórbico, levedura recombinante e método para aumentar a produção, a produtividade, ou o rendimento de um produto produzido por um microorganismo durante a fermentação
WO2024141710A3 (en) An aquaculture system and methods for removing glycerol from the aquaculture system
DE69611797D1 (de) Verfahren zur herstellung von ethanol
TW200516151A (en) Biocatalytic preparation of 1-cyanocyclohexaneacetic acid
NZ515762A (en) Method of producing a heparin-binding protein by expressing it in a mammalian cell that can be cultured in anaerobic conditions
CA2392463A1 (en) Novel use of uridine diphosphate glucose 4-epimerase
ATE271133T1 (de) Verfahren zur herstellung von arabitol durch kontinuierliche gärung
Turner Enzyme chemistry

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties